載入...

Testosterone, HDL and cardiovascular risk in men: the jury is still out

“Even when reductions in HDL-cholesterol are observed as a consequence of androgen therapy, the implications for cardiovascular risk modification remain highly uncertain.”

Na minha lista:
書目詳細資料
發表在:Clin Lipidol
Main Authors: Rubinow, Katya B, Page, Stephanie T
格式: Artigo
語言:Inglês
出版: 2012
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4219622/
https://ncbi.nlm.nih.gov/pubmed/25379057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.12.38
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!